Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference

Rhea-AI Summary

Wave Life Sciences (Nasdaq: WVE), a clinical-stage genetic medicines company, will have its CEO, Paul Bolno, present at the Chardan Virtual 4th Annual Genetic Medicines Conference on October 6, 2020, at 4:45 p.m. ET. The presentation will focus on the company’s commitment to developing life-changing treatments for genetic diseases through its proprietary PRISM platform. A live webcast will be available on the Wave Life Sciences Investor Relations page, with a replay accessible for 90 days post-event.

CAMBRIDGE, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the Chardan Virtual 4th Annual Genetic Medicines Conference on Tuesday, October 6, 2020 at 4:45 p.m. ET.

A live webcast of the presentation will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for 90 days following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contacts:
Kate Rausch
617-949-4827
krausch@wavelifesci.com

Graham Morrell
781-686-9600
gmorrell@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

 

FAQ

When is Paul Bolno presenting at the Chardan Genetic Medicines Conference for WVE?

Paul Bolno will present on October 6, 2020, at 4:45 p.m. ET.

Where can I watch the WVE presentation from the Chardan Conference?

The presentation can be viewed live on the Wave Life Sciences Investor Relations page.

What is the focus of Wave Life Sciences' presentation at the conference?

The presentation will highlight Wave Life Sciences' commitment to developing treatments for genetic diseases.

How long will the replay of the WVE presentation be available?

The replay will be available for 90 days after the live event.

What technology does Wave Life Sciences use for drug development?

Wave Life Sciences utilizes the PRISM platform for designing and producing stereopure oligonucleotides.